Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2012
11/13/2012US8309745 Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidant activity
11/13/2012US8309609 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
11/13/2012US8309604 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
11/13/2012US8309584 Sulfur containing pyrazole-heterocycle derivatives as cannabinoid CB1 receptor antagonists
11/13/2012US8309581 Benzimidazole derivatives
11/13/2012US8309565 Phosphonate compounds
11/13/2012US8309552 Immunomodulating heterocyclic compounds
11/13/2012US8309125 Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
11/13/2012CA2575758C Coenzyme q10-containing composition
11/13/2012CA2575396C Composition for capsule coating, capsule coating, and capsule using the same
11/13/2012CA2539467C Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide
11/13/2012CA2534314C Benzothiazole derivatives for the treatment of diabetes
11/13/2012CA2533747C Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors
11/13/2012CA2508180C Dimetalhydroxy malates
11/08/2012WO2012151476A1 Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions
11/08/2012WO2012151252A2 Composition and method for treatment of diabetes
11/08/2012WO2012150784A2 Novel indole derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic diseases containing same as active ingredient
11/08/2012WO2012150707A1 Low molecular weight compound which promotes induction of differentiation of stem cells into insulin-producing cells and method for inducing differentiation of stem cells into insulin-producing cells using low molecular weight compound
11/08/2012WO2012150675A1 Panaxadiol-containing composition
11/08/2012WO2012150245A1 Katp antagonists (glibenglamid) for use for promoting growth and/or treating hyperglycaemia of a premature infant
11/08/2012WO2012150202A1 Isoindolinone derivatives
11/08/2012WO2012124888A3 Composition comprising the extract of herbal combination for preventing or treating diabetic peripheral neuropathy
11/08/2012WO2012093809A3 New bicyclic compound for modulating g protein-coupled receptors
11/08/2012WO2012088379A9 Methods for treating metabolic disorders and obesity with gip and glp-1 receptor-active glucagon-based peptides
11/08/2012WO2012053003A9 A novel herbal oil for controlling blood sugar without risk of hypoglycemea
11/08/2012WO2011114271A8 2,3 dihydro- 1h - inden- 1 - yl -2,7 -diazaspiro [ 3.5 ] nonane derivatives and their use as antagonists or inverse agonists of the ghrelin receptor
11/08/2012US20120283332 Transdermal delivery of metformin
11/08/2012US20120283320 Stable, water-insoluble r-(+)-alpha-lipoic acid salt useful for the treatment of diabetes mellitus and its co-morbidities
11/08/2012US20120283319 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
11/08/2012US20120283307 Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
11/08/2012US20120283303 Use of n-aminoimidazole cytoprotective compounds for treating cell death and/or gsk-3 mediated diseases
11/08/2012US20120283299 Biguanide Derivative, A Preparation Method Thereof And A Pharmaceutical Composition Containing The Biguanide Derivative As An Active Ingredient
11/08/2012US20120283297 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
11/08/2012US20120283292 Fatty acid lenalidomide and their uses
11/08/2012US20120283282 Photoproducts of Tryptophan, Their Synthesis and Uses Thereof
11/08/2012US20120283271 Isoindolinone derivatives
11/08/2012US20120283269 Method and Compositions for Suppression of Aging
11/08/2012US20120283262 Pharmaceutical compositions comprising sigma receptor ligands
11/08/2012US20120283247 Diazepane acetamide derivatives as selective 11b-hsd1 inhibitors
11/08/2012US20120283243 Spiroindoline Modulators of Muscarinic Receptors
11/08/2012US20120283238 Irak inhibitors and uses thereof
11/08/2012US20120283236 Porphyrin Catalysts and Methods of Use Thereof
11/08/2012US20120283234 Bile Acid Derivatives As FXR Ligands For The Prevention Or Treatment Of FXR-Mediated Diseases Or Conditions
11/08/2012US20120283228 2alpha-Methyl and 2beta-Methyl Analogs of 19,26-Dinor-1alpha,25-Dihydroxyvitamin D3 and Their Uses
11/08/2012US20120283222 Heteroarylcarboxylic acid ester derivative
11/08/2012US20120283217 Modulators of amyloid-beta production
11/08/2012US20120283215 Pharmaceutical compositions which inhibit fkbp52-mediated regulation of androgen receptor function and methods of using same
11/08/2012US20120283203 Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia
11/08/2012US20120283197 Compositions Comprising a Glucose Anti-Metabolite, BHA, and/or BHT
11/08/2012US20120283185 Food composition and method of using same
11/08/2012US20120283182 Peptide Modulators of the deltaPKC Interaction with the d Subunit of F1F0 ATP Synthase/ATPase and Uses Thereof
11/08/2012US20120283181 Crystal forms of saxagliptin and processes for preparing same
11/08/2012US20120283180 Pea-based protein mixture and use thereof in a liquid nutritional composition suitable for enteral feeding
11/08/2012US20120283179 Pharmaceutical composition comprising a glp-1 agonist and methionine
11/08/2012US20120283178 Learning motivation improvers
11/08/2012US20120283170 Acylated Exendin-4 Compounds
11/08/2012US20120283169 Pharmaceutical composition, methods for treating and uses thereof
11/08/2012US20120283168 Template-fixed peptidomimetics with ccr10 antagonistic activity
11/08/2012US20120282359 Compositions, Kits, and Methods for the Treatment of Conditions Associated with Elevated Cholesterol Levels
11/08/2012US20120282358 Oral administration composition
11/08/2012US20120282343 Compositions for oral gene therapy and methods of using same
11/08/2012US20120282336 Bilayer tablet formulations
11/08/2012US20120282326 Compositions and methods related to mirna in diabetic conditions
11/08/2012US20120282279 Anti-Diabetic Compounds
11/08/2012US20120282269 Anti-IL-23 Antibodies
11/08/2012US20120282255 Methods and compositions for the treatment of alcoholism and alcohol dependence
11/08/2012US20120282252 5Imidazoquinolines and Pyrimidine Derivatives as Potent Modulators of VEGF-Driven Angiogenic Processes
11/08/2012US20120282250 Il-21 antagonists
11/08/2012US20120282198 Cosmetic and/or pharmaceutical composition comprising an extract of carob as active agent for activating aquaporin expression
11/08/2012US20120282184 Treatment of obesity
11/08/2012DE112009005072T5 Verfahren zur Herstellung eines Extrakts von Gynostaema pentaphyllum mit erhöhten Gehalten an Damulin A und Damulin B sowie pharmazeutische Zusammensetzungen davon zur Behandlung des metabolischen Syndroms A process for preparing an extract of Gynostemma Gynostaema with increased contents of Damulin A and B Damulin and pharmaceutical compositions thereof for the treatment of the metabolic syndrome
11/08/2012CA2834885A1 Composition and method for treatment of diabetes
11/08/2012CA2832390A1 Isoindolinone derivatives
11/07/2012EP2520307A1 Composition and functional food using polygonum cuspidatum butanol extract or ethyl acetate extract for treating and preventing obesity
11/07/2012EP2520300A1 Pharmaceutical composition for oral administration
11/07/2012EP2520299A1 Solid pharmaceutical composition for oral administration
11/07/2012EP2520298A1 Pharmaceutical composition comprising sulfonylureas (glibenclamide) or meglitinides for use for treating hyperglycaemia or for promoting growth of a premature infant
11/07/2012EP2520289A1 Norethisterone-containing patch
11/07/2012EP2519527A1 Thieno [2,3-b]pyridinedione activators of ampk and therapeutic uses thereof
11/07/2012EP2519514A2 Alpha4beta2 neuronal nicotinic acetylcholine receptor ligands
11/07/2012EP2519513A1 Diacylglycerol based alpha-lipoic acid derivatives as antioxidants and agents for blocking food intake
11/07/2012EP2519240A2 Pharmaceutical composition comprising metformin and rosuvastatin
11/07/2012CN1871240B Pyrrolopyrimidine thion derivatives
11/07/2012CN102766613A Talaromyces emersonii beta-glucanases
11/07/2012CN102766258A Resveratrol hydrophilic conjugate, its preparation method and application
11/07/2012CN102766204A Glucagon-like peptide-1 mutant polypeptide, its preparation method and application thereof
11/07/2012CN102766186A Preparation method and application of ecdysone-rich plant standardized extract
11/07/2012CN102764367A Medicine composition for treating diabetes mellitus and complications
11/07/2012CN102764334A Medicinal composition for treating hyperlipidemia
11/07/2012CN102764304A Method for improving non-oxidation rate of flavonoids in lotus leaves
11/07/2012CN102764287A Three-high prevention and treatment particulate agent
11/07/2012CN102764284A Sesquiterpene extract of tithonia diversifolia as well as preparation method and application thereof
11/07/2012CN102764270A Human body longevity factor supplement
11/07/2012CN102764269A Nasal cavity health care cleansing solution and preparation method thereof
11/07/2012CN102764262A Application of oleanolic acid and retinoic acid pharmaceutical composition to medicament for treating insulin resistance and diabetes
11/07/2012CN102763848A Health care product for lowering blood lipid and preparation process thereof
11/07/2012CN102356837B Combined food for reducing blood sugar
11/07/2012CN102274203B Method for improving moisture resistance of L-carnitine tea polyphenol capsule inclusion
11/07/2012CN102188367B Insulin glargine injecta and preparation method thereof
11/07/2012CN102180991B Comprehensive utilization method of pumpkin